Hong Kong Transportation Stock News

Founder led companies can be especially interesting when inflation, rates, energy costs, and growth momentum are all pulling markets in different directions. With central banks weighing inflation data, bond markets reacting to policy expectations, and sectors responding differently to trade, energy, and housing trends, many investors are looking for leaders who are deeply aligned with long term outcomes. This article focuses on that theme by using a founder led screener built around personal...

In recent days, BYD has accelerated its global push with new model previews, an overhauled overseas brand structure, a planned European plant led by former Hungarian foreign minister Peter Szijjarto, and a multi-year advanced materials partnership with Covestro for vehicles, batteries, and energy storage. Together with rising interest in Chinese EVs in markets like Canada and growing plug-in hybrid traction in Southeast Asia, these moves highlight BYD’s effort to deepen its international...

With inflation paths shaped by energy prices, mixed growth signals across Western economies, and pockets of strength in Asia-Pacific investment flows, many investors are looking for companies that combine financial resilience with credible earnings growth expectations. The Healthy high growth potential screener focuses on stocks where analysts see strong earnings growth over the next 3 years and where balance sheets appear sound enough to handle shifting rates, bond yields, and trade...

J&T Global Express Limited reported its second-quarter and half-year 2026 operating results, with total parcel volume reaching 9.18 billion for the quarter and non-China parcels rising to represent about one-third of the business. The company’s quarterly average daily parcel volume passing the 100 million mark, alongside rapid growth in Southeast Asia and other non-China markets, signals a meaningful shift toward a more globally balanced network. We’ll now examine how this rapid expansion in...

China Longyuan Power Group Corporation Limited reported past consolidated power generation for June 2026 of 5,348,794 MWh, a 7.48% year-on-year decline, with wind output down 9.73% and solar output down 0.63%, and year-to-date generation falling 2.19% to 38,782,781 MWh. An interesting contrast emerges as the company’s wind power output fell 6.67% year to date while solar power generation increased very significantly by 22.22%, highlighting an internal shift in its renewable mix. We will now...

As geopolitical tensions and energy market volatility capture global attention, Asian markets have shown resilience, with technology stocks benefiting from a push towards self-sufficiency. In this environment, growth companies in Asia with high insider ownership are particularly intriguing as they often signal strong confidence from those who know the business best.

Ruifeng Power Group (SEHK:2025) has entered a collaboration with Beijing Huizhi Guoke Technology to manufacture and sell intelligent underwater ship hull cleaning robots, a move that directly targets rising global demand for cleaner, more efficient shipping operations. See our latest analysis for Ruifeng Power Group. Set against this announcement, Ruifeng Power Group’s share price has gained momentum, with a 30 day share price return of 7.75% and a 90 day share price return of 16.03%, while...

Health and Happiness (H&H) International Holdings (SEHK:1112) has issued new earnings guidance for the six months to 30 June 2026, indicating Reported Net Profit growth of more than 7 times compared with last year’s low base. See our latest analysis for Health and Happiness (H&H) International Holdings. The upbeat earnings guidance comes after a sharp 33.57% 1 month share price return and a 13.55% year to date share price return. The 1 year total shareholder return of 38.67% and 3 year total...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Chow Tai Fook Jewellery Group (SEHK:1929) is in focus after the passing of independent non executive director Mr. Kwong Che Keung, Gordon. He also chaired the audit committee and sat on the remuneration committee. See our latest analysis for Chow Tai Fook Jewellery Group. Chow Tai Fook Jewellery Group’s recent governance shock comes as the stock trades at HK$12.03, with a 1 day share price return of 1.78% and a 7 day share price return of 5.43%. Over the same period, the 1 year total...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

China Lesso Group Holdings Limited ( HKG:2128 ), is not the largest company out there, but it saw a decent share price...

While Harbin Electric Company Limited ( HKG:1133 ) might not have the largest market cap around , it saw significant...

Viewing insider transactions for Hang Lung Group Limited's ( HKG:10 ) over the last year, we see that insiders were net...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Last week, China Uptown Group Company Limited ( HKG:2330 ) insiders, who had purchased shares in the previous 12 months...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Pico Far East Holdings Limited's ( HKG:752 ) robust earnings report didn't manage to move the market for its stock. Our...

Xiaomi’s share price has swung sharply over the past few years, and with the stock up 148.6% over 3 years but still down heavily over the last 12 months, the key tension now is that the Discounted Cash Flow (DCF) intrinsic value estimate points to around 10.1% upside while the broader valuation checks suggest the stock is closer to fairly priced. Xiaomi has returned 148.6% over the past 3 years, which puts the recent weakness in a longer track record of strong gains for long term...

Chevalier International Holdings (SEHK:25) has just posted its FY 2026 results, with first half revenue of HK$3.9 billion and EPS of HK$0.77, while trailing twelve month figures show revenue of HK$8.2 billion and EPS of HK$1.39. Over the past few reporting periods, the company has seen revenue range between HK$4.0 billion and HK$5.2 billion per half year, alongside EPS that has swung from a loss of HK$1.84 per share in FY 2025 H2 to a profit in the latest period. This sets up this release as...

Stella International Holdings (SEHK:1836) reported unaudited revenue growth for the quarter and half year to 30 June 2026, with sales edging higher in both periods compared with the same time last year. See our latest analysis for Stella International Holdings. Stella International Holdings’ HK$12.79 share price has risen over the past week but is still down 6.2% over 30 days and 16.5% over 90 days. However, the 3 year total shareholder return of 119.9% and 5 year total shareholder return of...

China Mobile (SEHK:941) is back in focus after HKBN Ltd. renewed and expanded its Master Agreements with China Mobile Hong Kong and China Mobile International, extending a broad range of telecom and technology services to 2028. See our latest analysis for China Mobile. The HKBN renewal arrives while China Mobile’s share price has slipped, with a 30 day share price return of 2.09% decline and a year to date share price return of 4.61% decline, even as the 5 year total shareholder return of...

China National Building Material (SEHK:3323) issued unaudited guidance for the six months to 30 June 2026, flagging an expected RMB 890 million loss compared with a RMB 1,360 million profit a year earlier. See our latest analysis for China National Building Material. The guidance lands after a weak run for China National Building Material's stock, with the share price down 27.41% over 30 days and the 1 year total shareholder return declining 8.64%, while the 3 year total shareholder return is...

Innovent Biologics recently announced an exclusive license agreement granting Spero Therapeutics rights to develop and commercialize IBI355 outside Greater China, with Innovent eligible for up to approximately US$1.10 billion in upfront and milestone payments plus tiered royalties. The arrangement effectively turns IBI355 into a globally partnered asset, allowing Innovent to keep Greater China rights while leveraging Spero’s international development plans in IgG4-related disease and...